Skip to main content
letter
. 2018 Oct 16;14:2646–2650. doi: 10.3762/bjoc.14.242

Figure 1.

Figure 1

NDH-2 is a validated target for 1 with an MIC of 1.1 µg/mL against M. tuberculosis.